Research graph
References from Prognostic significance of pretreatment peripheral blood inflammatory biomarkers in elderly patients with locally advanced cervical cancer undergoing definitive chemoradiotherapy. Local targets link to admitted publications; unresolved targets remain external evidence.
Cancer statistics, 2026
10.3322/caac.70043 · 2026 · External reference
National and subnational trends in cancer burden in China, 2005-20: an analysis of national mortality surveillance data
10.1016/s2468-2667(23)00211-6 · 2023 · External reference
Cancer incidence and mortality in China, 2022
10.1016/j.jncc.2024.01.006 · 2024 · External reference
Cervical cancer burden and trends in China, 2000-2020: Asia-Pacific international comparisons and insights for elimination goals
10.20892/j.issn.2095-3941.2025.0386 · 2025 · External reference
Cervical cancer, version 2.2026, NCCN Clinical Practice Guidelines in Oncology
10.6004/jnccn.2025.0057 · 2025 · External reference
The role of inflammation in cancer: mechanisms of tumor initiation, progression, and metastasis
10.3390/cells14070488 · 2025 · External reference
Role of CCL8 in cancer immunity and tumor progression: implications for cancer treatment
10.1016/j.bbcan.2025.189502 · 2025 · External reference
Prognostic value of inflammatory markers NLR, PLR, and LMR in gastric cancer patients treated with immune checkpoint inhibitors: a meta-analysis and systematic review
10.3389/fimmu.2024.1408700 · 2024 · External reference
Albumin and derived neutrophil-to-lymphocyte ratio is a novel prognostic factor for patients with esophageal squamous cell carcinoma
10.1245/s10434-022-11868-8 · 2022 · External reference
The prognostic nutritional index is prognostic factor of gynecological cancer: a systematic review and meta-analysis
10.1016/j.ijsu.2019.05.018 · 2019 · External reference
Combined preoperative platelet-albumin ratio and cancer inflammation prognostic index predicts prognosis in colorectal cancer: a retrospective study
10.1038/s41598-025-15309-w · 2025 · External reference
Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma
10.1158/1078-0432.ccr-14-0442 · 2014 · External reference
A novel systemic inflammation response index (SIRI) for predicting the survival of patients with pancreatic cancer after chemotherapy
10.1002/cncr.30057 · 2016 · External reference
The diagnostic efficacy of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in ovarian cancer
10.1007/s00011-017-1026-6 · 2017 · External reference
Prognostic value of changes in neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR) and lymphocyte-to-monocyte ratio (LMR) for patients with cervical cancer undergoing definitive chemoradiotherapy (dCRT)
10.1016/j.ijrobp.2019.06.1061 · 2020 · External reference
Tumour-associated neutrophils in patients with cancer
10.1038/s41571-019-0222-4 · 2019 · External reference
Target neutrophil heterogeneity and plasticity in cancer
10.1186/s13045-025-01731-0 · 2025 · External reference
Myeloid cell-targeted therapies for solid tumours
10.1038/s41577-022-00737-w · 2023 · External reference
Monocytes in the tumor microenvironment
10.1146/annurev-pathmechdis-012418-013058 · 2021 · External reference
T cell dysfunction and therapeutic intervention in cancer
10.1038/s41590-024-01896-9 · 2024 · External reference
Adjusting the scope of natural killer cells in cancer therapy
10.1038/s41423-025-01297-4 · 2025 · External reference
Targeting metabolic dysfunction of CD8 T cells and natural killer cells in cancer
10.1038/s41573-024-01098-w · 2025 · External reference
The pretreatment neutrophil-to-lymphocyte ratio predicts therapeutic response to radiation therapy and concurrent chemoradiation therapy in uterine cervical cancer
10.1007/s10147-015-0807-6 · 2015 · External reference
Evaluating the prognostic relevance of neutrophil-to-lymphocyte ratio in cervical cancer: a systematic review and meta-analysis
10.3389/fonc.2024.1461175 · 2024 · External reference
A novel prognostic marker systemic inflammation response index (SIRI) for operable cervical cancer patients
10.3389/fonc.2020.00766 · 2020 · External reference
The systemic inflammation response index (SIRI) predicts survival in advanced non-small cell lung cancer patients undergoing immunotherapy and the construction of a nomogram model
10.3389/fimmu.2024.1516737 · 2024 · External reference
Predictive effect of the systemic inflammation response index (SIRI) on the efficacy and prognosis of neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer
10.1186/s12893-024-02384-5 · 2024 · External reference
Peripheral blood inflammatory biomarkers dynamics reflect treatment response and predict prognosis in non-small cell lung cancer patients with neoadjuvant immunotherapy
10.1111/cas.15964 · 2023 · External reference
Nomogram for predicting primary resistance to anti-PD-1 therapy in advanced gastric cancer based on dynamic inflammatory markers: a multicenter retrospective study
10.1016/j.intimp.2025.115122 · 2025 · External reference
Radiotherapy-induced high neutrophil-to-lymphocyte ratio is a negative prognostic factor in patients with breast cancer
10.3390/cancers12071896 · 2020 · External reference
